Blood Preparation Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies, and Forecasts, 2015 To 2022

The demand for blood preparation is correlated to the need for blood transfusion. Blood transfusion is a procedure carried out to replace blood or its portions that are lost due to surgery, injury or a medical condition. It is often necessary in cases of liver malfunction, blood disorders, infections, severe burns, cancer and gastrointestinal bleeding. Before the 1960s, most of the blood transfused was whole blood. However, in the later years, transfusion of individual components of blood like red cells, platelets and plasma came into practice. For Market Research Report on “Blood Preparation Market ” Visit - The global demand for blood preparation is expected to be more than $50 billion by 2022. Rising geriatric population, higher admissions of patients for emergency procedures, technological advances, high healthcare expenditures, strong promotion of blood donation campaigns, and growing incidences of thrombocytosis and related complications are driving growth of the blood preparation market Product Categories The blood preparation market can be segmented into whole blood, derivatives and components. Whole blood accounted for a majority (approx 45.0%) of the market share in 2014. The blood derivatives market was valued at more than $10 million in the same year. This can be attributed to greater demand for blood transfusion. Ongoing research activities for the development of blood-derived medicines and large-scale commercial applications of new drugs are expected to fuel growth in future. The development of better technology that will enable separation of blood into its various components while retaining their activity will also positively affect global blood preparation market. Plasma is rich in proteins that are used by the human body for clotting and fighting infection. Individual plasma proteins are further purified and used to treat patients with specific plasma protein deficiencies. Therefore, plasma collection and manufacture of plasma derived therapeutics is an important product category. The removal of leukocytes present in different blood products, reduces associated risks like platelet refractoriness, HLA alloimmunization and nonhemolytic febrile transfusion reactions. Higher requirement for specific blood components is expected to drive the blood preparation market in the coming years. In the antithrombotic drugs category, anticoagulants accounted for the largest market share in 2014. This was due to the rising number of geriatrics, growing rate of thrombosis related disorders, demand for superior drugs and rising government initiatives for increasing awareness of thrombosis disorders. Regional Insights North America was the most lucrative regional blood preparation market in 2014 followed by Europe. The contribution of these regions is expected to remain strong in the forthcoming years owing to advanced healthcare infrastructure, high patient awareness and rising cases of thrombocytosis disorders. Public awareness campaigns initiated by governmental organizations for prevention and treatment of thrombocytosis and blood collection in these regions will also accelerate market growth. The expansion of health coverage in the US as a part of its healthcare reforms has been a contributor to higher demand for blood preparation in that region. Close to 900,000 people in US are affected by blood clots in their legs and lungs each year. This has led to a public education initiative ‘Stop the Clot, Spread the Word’ by the National Blood Clot Alliance (NBCA) and Centers for Disease Control and Prevention (CDC). In 2012, more than 1300 blood establishments secured more than 20 million whole blood and blood components donations in the EU region. The European Commission co-funds projects focusing on various parts of the blood transfusion chain in collaboration with several organizations across Europe. Additionally, the Plasma Protein Therapeutics Association (PPTA) promotes availability and access to safe and quality plasma protein therapeutics in the European region. In the coming years, the fastest growth is expected to arise from developing markets of Asia Pacific and Latin America due to factors like large populations, untapped markets, growing incidences of blood disorders and growing demand for blood transfusion. Competitive Profile The global blood preparation market comprises of key players like Pfizer Inc., Leo Pharma Inc., Astrazeneca Co., Bristol-Myers Squibb Co., Sanofi Aventis, Baxter Healthcare Corp., Hisunny Chemical Co. and Celgene Corp. The success of these industry participants is linked to their ability to introduce innovative, efficient and affordable treatment solutions through intensive research and development. Blood Preparation Market Information Source: Grand View Research      

Request free sample